A pharmaceutical preparation containing a 3-(2H)-furanone derivative for prevention and/or treatment of cataracts
申请人:KIKKOMAN CORPORATION
公开号:EP0737476A2
公开(公告)日:1996-10-16
In order to prevent or treat cataracts, present invention features 3(2H)-furanone derivatives having 3(2H)-furanone skeleton as a main structure and/or pharmaceutically acceptable salts thereof, pharmaceutical preparations containing the derivatives and/or the salts thereof, treatment methods of cataracts, and their use. The 3(2H)-furanone derivatives have excellent effects for the prevention and/or treatment of cataracts, for instance, senile cataracts caused by oxidation disorder. Particularly, the pharmaceutical preparations have good effect for the prevention and/or treatment of cataracts when they are administrated as ophtalmics.
为了预防或治疗白内障,本发明的特点是以3(2H)-呋喃酮骨架为主要结构的3(2H)-呋喃酮衍生物和/或其药学上可接受的盐、含有这些衍生物和/或其盐的药物制剂、白内障的治疗方法及其用途。3(2H)-呋喃酮衍生物在预防和/或治疗白内障(例如,由氧化紊乱引起的老年性白内障)方面具有极佳的效果。特别是,这些药物制剂作为眼药使用时,对预防和/或治疗白内障具有良好的效果。